← Back to headlines
Cytokinetics Poised for Market Share Gain with Myqorzo in Cardiac Myosin Space
Cytokinetics, Incorporated (CYTK) is positioned to gain market share with its drug Myqorzo in the cardiac myosin treatment sector.
19 Feb, 19:41 — 19 Feb, 19:41
Sources
Showing 1 of 1 sources
Related Stories
OpenAI Terminates Partnership With SpaceX-Backed AI Tool Cursor
30m ago
NASA to launch $4.3bn Roman space telescope to study dark matter and exoplanets
52m ago
Widow Files Lawsuit Against Singapore Airlines Over Turbulence Fatality
1h ago
Nepal flood damage could cost up to a tenth of economy to rebuild
1h ago